Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

This publication has 34 references indexed in Scilit:

• Tissue typing in support of unrelated hematopoietic cell transplantation
  Tissue Antigens, 2003
• The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors
  Blood, 2002
• Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
  Blood, 2001
• Improving availability and safety of unrelated donor transplants
  Current Opinion in Oncology, 2000
• The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia
  Bone Marrow Transplantation, 2000
• Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient
  Blood, 1998
• LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1
  Transplantation, 1998
• Hematopoietic stem cell transplants from unrelated donors
  Immunological Reviews, 1997
• The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
  Blood, 1995
• MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
  Transplantation, 1991